SLAS Europe has revealed details of the Biology Unveiled track at the upcoming meeting in Brussels, Belgium on May 23-26.
The other three tracks are Frontiers in Technology, Shaping the Future of Therapeutics and Bio-Entrepreneurship in Europe.
The Biology Unveiled track will feature scientific sessions focusing on the hot topic of personalised medicine, along with advances in the uses of CRISPR and vessels-on-a-chip.
Sixteen speakers will showcase the latest drug discovery research in this vast topic based on tiny particles.
Sessions in this track include:
- Bioengineering Organoid Fate and Morphogenesis – Adrian Ranga, KU Leuven
- Engineering Vessels-on-a-Chip to Study Human Vascular Diseases – Guillaume Dumenil, Institut Pasteur
- High-Throughput Functional Genomics Using CRISPR Base Editing in Cancer Cells – Matthew Coelho, Wellcome Sanger Institute
- Microfluidic Palette for in vitro Modelling Human Neuronal Circuit – Quyen Do, University of Oxford
Delegates can also take one of the pre-conference Short Courses on May 23, with courses offered in microfluidic systems, label-free cell assays, high-content screening and target validation.
Another option is to attend a Special Interest Group meeting. Five meetings will take place between Wednesday and Thursday and they are open to all attendees.
View the Full SLAS Europe 2023 Programme.
Non-award eligible poster presentation submissions are still being accepted until May 1 in a wide range of topics within this year’s educational tracks.
